Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Individuals with both fatty liver diseae and obesity had the greatest risk of sleep apnea.
Among people who inject drugs, integrating antiviral therapy with other care led to improved outcomes.
But a simple improvement in dietary intake reversed fatty liver disease and staved off cancer.
People who drastically reduced calories twice a week also saw reductions in liver stiffness and body weight.
Sintilimab plus chemotherapy infused into a liver artery may offer the chance for a cure.
One in five deaths among low-income adults with advanced fibrosis could be averted if they had access to adequate food.
Disruptions in access to treatment and harm reduction services could set back effort to eliminate hep C in the U.S.
A companion study will look at liver biopsy results to confirm these findings from noninvasive tests.
However, some 10% experienced liver decompensation even after antiviral therapy.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Previous studies of the association between tenofovir and COVID-19 outcomes in people with HIV have yielded mixed results.
Compared with current practices, routine screening could prevent 23,000 deaths from liver disease.
Low-barrier care and access to multiple services in one place can improve outcomes for people experiencing homelessness or unstable housing.
Positive diagnostic tests and drug prescriptions dropped 40% in July 2020 compared with earlier years.
Suppression of hepatitis B virus with antiviral treatment lowered the risk of hepatocellular carcinoma by 58%.
The protein subunit vaccine provides 100% protection against moderate or severe disease, hospitalization and death.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.